WELL Health Technologies Corp. (TSE:WELL) Given Average Recommendation of “Buy” by Brokerages

WELL Health Technologies Corp. (TSE:WELL) has been assigned an average rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is C$7.35.

Several brokerages recently issued reports on WELL. Canadian Imperial Bank of Commerce upgraded WELL Health Technologies from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 3rd. Scotiabank reduced their price objective on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th.

WELL Health Technologies Stock Performance

Shares of TSE:WELL opened at C$4.08 on Friday. WELL Health Technologies has a 12-month low of C$3.58 and a 12-month high of C$6.08. The company’s 50 day moving average price is C$4.11 and its two-hundred day moving average price is C$4.41. The firm has a market cap of C$1.04 billion, a PE ratio of -45.33, a PEG ratio of -1.93 and a beta of 0.85. The company has a quick ratio of 1.02, a current ratio of 0.92 and a debt-to-equity ratio of 73.92.

About WELL Health Technologies

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.